SCHEMBL6955378

SCHEMBL6955378

O=C(NCCc1ccccn1)NSc1nc2ccccc2[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
CYP2E1 P05181 1/20 0.53
CYP2C8 P10632 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2B6 P20813 1/20 0.53
CYP2C19 P33261 1/20 0.53
SLC40A1 Q9NP59 7/20 0.48
PDE10A Q9Y233 1/20 0.47
CNR1 P21554 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6958204 0.88 SLC40A1 (0.47) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6959260 0.87 SLC40A1 (0.46) CYP1A2CYP2E1CYP2C8CYP2D6CYP2C9
SCHEMBL6957395 0.80 MAPK1 (0.53) CYP1A2CYP2C9CYP2C19SLC40A1CNR1
SCHEMBL6963530 0.80 HTT (0.44) CYP1A2CYP2C9CYP2C19HTTKMT2A
SCHEMBL8890569 0.80 KMT2A (0.55) CNR1KMT2ASMN1; SMN2LMNAMEN1
SCHEMBL6958136 0.80 SMN1; SMN2 (0.53) HTTKMT2ASMN1; SMN2LMNAMEN1
SCHEMBL6958370 0.80 ALDH1A1 (0.48) CNR1HTTKMT2ASMN1; SMN2LMNA
SCHEMBL6954596 0.80 RAB9A (0.53) CYP1A2CYP2C9CYP2C19SLC40A1HTT
SCHEMBL6950919 0.79 LMNA (0.45) HTTKMT2ASMN1; SMN2LMNA
SCHEMBL6957950 0.79 LMNA (0.50) CNR1HTTKMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0540143-B1 Compounds and methods for inhibition of HIV and related viruses MEDIVIR AB (SE) 2003-02-05 EP disclosed
US-5658907-A THIOUREA VIRICIDES MEDIVIR A/B (SE) 1997-08-19 US disclosed
US-5593993-A VIRICIDES FOR HTLV TREATMENT OF AIDS MEDIVIR AB (SE) 1997-01-14 US disclosed
EP-0540143-A2 Compounds and methods for inhibition of HIV and related viruses Medivir Aktiebolag (SE) 1993-05-05 EP disclosed
WO-1993003022-A1 COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES MEDIVIR AB (SE) 1993-02-18 WO disclosed